secwatch.observer — SEC 8-K summary
======================================

Issuer:     XOMA Royalty Corp (XOMA)
CIK:        0000791908
Form:       8-K
Filed at:   2022-11-22T23:59:59+00:00
Accession:  0001193125-22-290445
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

XOMA acquires ebopiprant from ObsEva for $15M cash plus milestone earn-outs
---------------------------------------------------------------------------

- XOMA pays $15M cash at closing to ObsEva for ebopiprant; assumes IP estate and all license agreements including Organon sublicense.
- XOMA eligible for up to $475M in development, regulatory, and sales milestones from Organon; will pay ObsEva up to $98M of those.
- Upon commercialization, XOMA receives low- to mid-teen royalties from Organon and pays mid-single-digit royalty to Merck KGaA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/791908/000119312522290445/0001193125-22-290445-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/791908/000119312522290445/d396302d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-290445

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer